Pain Management in Fibromyalgia: Comparing Duloxetine, Pregabalin, and Milnacipran
Author Information
Author(s): Muacevic Alexander, Adler John R, Faizan Ejaz Khawaja, Wani Rehan, Akbar Amna, Umaira Khan Qudsia, Hifza Ishtiaq, Amir Muhammad, Ali Amir Iqbal, Khan Shahid
Primary Institution: Abbas Institute of Medical Sciences, Muzaffarabad, PAK
Hypothesis
How do duloxetine, pregabalin, and milnacipran compare in managing pain, quality of life, and sleep quality in fibromyalgia patients?
Conclusion
Duloxetine was found to be the most effective treatment for improving pain, quality of life, and sleep quality in fibromyalgia patients.
Supporting Evidence
- Duloxetine significantly reduced pain and improved sleep and quality of life.
- Pregabalin was effective for pain and sleep but less so for quality of life.
- Milnacipran showed modest effectiveness in managing fatigue.
Takeaway
This study looked at three medicines for fibromyalgia and found that duloxetine worked the best for helping with pain and sleep.
Methodology
A prospective cohort study with 193 fibromyalgia patients, comparing the effects of duloxetine, pregabalin, and milnacipran over nine months.
Potential Biases
Self-reported outcome measures may introduce bias.
Limitations
Single-center trial design may limit generalizability and lack of a placebo-controlled group.
Participant Demographics
Participants were mostly female (78%) with an average age of 47.8 years.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website